MetLife Investment Management’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $160K | Buy |
37,620
+19,945
| +113% | +$85K | ﹤0.01% | 2299 |
|
|
2025
Q1 | $66.5K | Sell |
17,675
-6,020
| -25% | -$22.6K | ﹤0.01% | 2659 |
|
|
2024
Q4 | $138K | Hold |
23,695
| – | – | ﹤0.01% | 2479 |
|
|
2024
Q3 | $283K | Hold |
23,695
| – | – | ﹤0.01% | 2100 |
|
|
2024
Q2 | $256K | Buy |
23,695
+8,790
| +59% | +$95.1K | ﹤0.01% | 2093 |
|
|
2024
Q1 | $169K | Hold |
14,905
| – | – | ﹤0.01% | 2289 |
|
|
2023
Q4 | $209K | Hold |
14,905
| – | – | ﹤0.01% | 2222 |
|
|
2023
Q3 | $184K | Hold |
14,905
| – | – | ﹤0.01% | 2265 |
|
|
2023
Q2 | $135K | Buy |
+14,905
| New | +$135K | ﹤0.01% | 2509 |
|
|
2022
Q1 | – | Sell |
-9,573
| Closed | -$89.6K | – | 2756 |
|
|
2021
Q4 | $89.6K | Hold |
9,573
| – | – | ﹤0.01% | 2438 |
|
|
2021
Q3 | $264K | Buy |
9,573
+3,962
| +71% | +$109K | ﹤0.01% | 1908 |
|
|
2021
Q2 | $157K | Hold |
5,611
| – | – | ﹤0.01% | 2304 |
|
|
2021
Q1 | $186K | Buy |
+5,611
| New | +$186K | ﹤0.01% | 2097 |
|